keytruda merck - Search News

News

Merck To Cut $3B Costs By 2027

Bloomberg on MSN · 2d

Merck Cuts $3 Billion in Costs as Keytruda Reign Nears End

Merck & Co. is slashing $3 billion from its annual spending as it braces for off-brand competition to its cancer drug Keytruda, the best-selling medicine in the world.

Seeking Alpha on MSN · 2d

Merck plans $3B cost cuts as Keytruda faces patent cliff

Merck (NYSE:MRK) is cutting $3 billion from its annual expenses as it prepares for generic competition to its blockbuster cancer drug, Keytruda. The Rahway, New Jersey-based company announced Tuesday it will reduce administrative,

Merck unveils $3bn cost-cutting plan to support pipeline and new product launches

Merck & Co – known as MSD outside of the US and Canada – has unveiled a new cost-cutting plan aimed at saving $3bn every year by the end of 2027.

1d

Merck's $3B Shock Move: Is This the End of the Keytruda Era?

Shipments to China are now paused through the end of 2025, dragging global sales of the HPV vaccine down 55% last quarter.

20h

Cautious Optimism As Merck Leans On Oncology Amid Gardasil Vaccine Concerns

Merck Q2 earnings beat estimates but revenue fell short. Gardasil sales dropped while Keytruda and other treatments drove ...

1don MSN

Merck extends pause on China Gardasil shipments to year end, shares slip

Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to ...

1d

Merck plans spending shift to boost business beyond Keytruda

Facing an end to Keytruda's market exclusivity, the company will cut $3 billion in costs that it plans to redeploy in support ...

Fierce Pharma2d

Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027

Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said ...

Merck moves to cut $3B, jobs in latest restructuring

Along with its financial results for the second quarter of 2025, Merck revealed a restructuring plan to save $3 billion by ...

2don MSN

Merck to extend pause on China Gardasil shipments to year end

Merck & Co said on Tuesday it was extending its hold on Gardasil shipments to China until at least the end of 2025 due to ...

1d

Merck CEO Sees Minimal EU Tariffs Impact, Warns Of Gardasil Challenges

Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results